In a study conducted using data from CPRD, insulin monotherapy was reported to be associated with a significantly higher risk of MACE, cancer, or death when compared with insulin in combination with metformin (1.51, 1.28–1.78) [18]. The gene discussed is INS; the disease is cancer.